Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Effat S. Emamian(Novel (United States)), Joseph A. Gogos(Columbia University)
Cited by 919
Related Papers
AKT/GSK3 signaling pathway and schizophrenia
|Frontiers in Molecular Neuroscience|2012|221
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes
|The International Journal of Neuropsychopharmacology|2011|62